Retractable Technologies (RVP) Total Non-Current Liabilities (2018 - 2026)
Retractable Technologies' (RVP) quarterly Total Non-Current Liabilities came in at $10.9 million in Q1 2026, up 5.58% YoY from $10.3 million in Q1 2025, and up 7.43% on a QoQ basis from $10.1 million in Q4 2025.
Retractable Technologies (RVP) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Retractable Technologies (RVP) has 9 years of Total Non-Current Liabilities data on file, last reported at $10.9 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 5.58% year-over-year to $10.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.9 million (up 5.58% YoY) and the FY2025 annual result came in at $10.1 million, up 4.62% from the prior year.
- Total Non-Current Liabilities climbed to $10.9 million in Q1 2026, from $10.1 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $30.2 million in Q1 2022 to a low of $8.0 million in Q1 2024.
- A 5-year average of $12.2 million and a median of $10.3 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities slumped 64.2% — and 2025, when it increased 28.39%.
- Tracing RVP's Total Non-Current Liabilities over 5 years: stood at $13.7 million in 2022, then declined by 22.37% to $10.6 million in 2023, then retreated by 8.77% to $9.7 million in 2024, then gained by 4.62% to $10.1 million in 2025, then climbed by 7.43% to $10.9 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $10.9 million (Q1 2026), $10.1 million (Q4 2025), and $10.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Retractable Technologies | 21.67 Mn | -18.20 Mn | 190,852.00 | 13.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.88 Mn |
| Dec 31, 2025 | 10.13 Mn |
| Sep 30, 2025 | 10.25 Mn |
| Jun 30, 2025 | 9.70 Mn |
| Mar 31, 2025 | 10.31 Mn |
| Dec 31, 2024 | 9.68 Mn |
| Sep 30, 2024 | 9.01 Mn |
| Jun 30, 2024 | 8.49 Mn |
| Mar 31, 2024 | 8.03 Mn |
| Dec 31, 2023 | 10.61 Mn |
| Sep 30, 2023 | 10.57 Mn |
| Jun 30, 2023 | 10.26 Mn |
| Mar 31, 2023 | 11.75 Mn |
| Dec 31, 2022 | 13.67 Mn |
| Sep 30, 2022 | 16.59 Mn |
| Jun 30, 2022 | 17.91 Mn |
| Mar 31, 2022 | 30.17 Mn |
| Dec 31, 2021 | 38.18 Mn |
| Sep 30, 2021 | 38.09 Mn |
| Jun 30, 2021 | 49.59 Mn |